Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Sleven, You bloated again - as so often before. This has nothing to do with you what so ever (beside - as I recall you actually started the rumor 'Brave not successful' - and ended being very offended 'on everyone' ).
--------------------------
Post were for JR - offering the other day 'to place his mail here - with Brave researchers saying endpoint not met' - shouldn't be that hard to understand with your sharp sense of logic.
JR, You promised couple of days ago to 'show mail proof' - of your korrespondance with responsible researchers behind the BRAVE study - that the study didn't meet the endpoints.
-------------------------
Haven't seen that response / proof for your 'talking Brave results down' - before the results are even published ?
Please - copy the mail in question here - for all to see - as you yourself surgested !!!
Whala, Thanks - your answer here 'actually comforting' - as far as 'the delisting goes' - as I read it !
------------------------
There is still time for Amarin - to regain trust in the future - second ½ of 2024. Taking SP above $1 would be good for a start - before to long ✌️
Whala, The bigger the 'Pump' - the better - as long as what spoken is the truth. Wee need all the help we can get right now !
-----------------------------
Anyone know 'how long to delisting' - has warning been given 'again' ?
North, Talking Ozempic - did you see the interview below ?
https://tuckercarlson.com/the-case-against-ozempic
liamlinden, Up $128k - did you sell then ? 🙂
Irish, Think you might just be right here.
-----------------------------------
Remember - some weeks back - he spins a story of 'his wife working from home' - him "accidently overhearing" - a talk with a patient of his wife - with no luck trying to defend the 'price for Vascepa' compared to a Statin.
His 'usual' - every chance placing needles in the confidence and trust in Amarin and Vascepa - this 'imaginary patient conference of his wife' - a little over the top in spinning - for anyone on this board to believe !
Whala, Will this be aloud to stand - as a result of the 2020- 21 World wide virus attack.
--------------------------------
Juli 4. coming up - a great tribute to your big Country - of combined very different States 🙂
JR, Every pro Day Trader 'Shorts' - every pro HF 'Shorts' - it is part of the game in the HF finance money world - given where Amarin stock is' at the moment.
------------------------------
What is important to remember here is - that a HF like Sarissara can/could invest 'in whatever stock in the marked - and 'Short' - if they felt it were 'best investment plan.
------------------------------
This is NOT what Sarissa and Denner have done around Amarin. There is clearly a long term strategy and plan - in using the effort and energy in taking on KM and 'old board' in the Proxy fight.
Truth is' where Amarin are' after the Du-disaster' (opening the door for FREE - for every aggressive generic company) - we couldn't have hoped for a better situation - than Sarissa and Denner taking over.
Lemm, Get your point. Honestly haven't followed the case very close.
You say its 'not about the fraudulent killed 6 patents' - but about infringement frem generics - on FDA CDV approval 2019.
And you are of course right - even it all started with the patents being disqualified - from 'not a chemist' - not a scientist - not a specialist in Bio.
Amarin were killed (not dead though) - by a populist liberal female judge - who really had no idea about the value of VASCEPA and the +10-year research by specialists - which she shoots down and undermines in seconds.
north, You have been a patent lawyer for 55 years - what I have heard. Legal stuff for me in the same period - i honestly know close to nothing about locally - even less in complex legal systems in the many states of America.
---------------------------
From your answer - I understand that in fact - an extension of patent period has happened in the Courts of US - even way back in time.
SP of AMRN after the current positive legal announcement shows' - that this is not 'in itself' something - that will blow Amarin out of the water bigtime'.
But still 'an important opening' for a change in the US - that has the potential of being significant in the not to far future :)
Marjac, As always - thanks for your pro evaluation of the legal situation at hand - which I hear you say - 'is the best it has been since the fatal blow in Nevada marts 2020'.
Talking best case - has there ever been a patent case in USA - where patents were reinstated and prolonged (say to 2035) as a compensation for the patent-years lost - as result of an earlier ruling based on fraud ?
DCM8, Very impressive market research - looking at icosapent ethyl (EPA) . Thanks !
ProLiberty, Agreed in headlines of your constructive thinking.
What we all have to remember is that Sarissa is a very experienced HF - that is in every way in known terrority with undervalued Bio company Amarin - which is exactly what Denner have specialized in.
As you point out - they knew that generics would move in on Amarin revenu when they entered - but given big cash holding and no debt - reducing cost everyway possibly - they would gain the necessary time to recover - and from there go for the end goal - BO to a big Pharma Company.
Advise - newer mention Trump to Whala - as you saw - He Shortens 🙂
BBI, Looking at financials for Amarin at Nasdaq is no fun experience. Profit falling all the way.
Why I bring it here anyway - is that it actually in only two numbers - looking left - scrolling to the bottom of page - shows precisely your point about the KM leadership - and the current Sarissa / Denner period after the Proxy.
Even profits has fallen dramatically in pressure from generics - the negative net income has been brought down to half. It does give hope for the future - even headwinds are many.
https://www.nasdaq.com/market-activity/stocks/amrn/financials
------------------------------
Sales, General and Admin.
23 $199,938
22 $304,416
21 $408,334
20 $463,312
MA52TA, Whala - again' - and again' expose himself as 'doing everything to talk opportunitets and value of Amarin DOWN' - much as possible.
---------------------------
Plus 20.000 posts - No AMRN shares ????
Why number of posters think he is indeed Dr. MO Nissen !
The legal cases started by Amarin - and against Amarin are debated a lot on the board.
A good place for to find some 'cooked down' knowledge of what it is all about - is the site below:
First the latest summery from April 17. 2024
https://fedcircuitblog.com/2024/04/17/argument-recap-amarin-pharma-inc-v-hikma-pharmaceuticals-usa-inc/
Under here - total list of Amarin related articles:
https://fedcircuitblog.com/?s=Amarin&data=all
What effect are you seeing from your efforts to stop naked short selling of your stock?
o
We’ve contacted various authorities, and they’re taking a closer look at the issue. We were on the Nasdaq Reg SHO threshold list for months, which indicates unusual trading activity, and the rate of failures to deliver on our stock has been abnormal. If this is what it appears to be—illegal naked short selling—then the perpetrators need to be criminally prosecuted, possibly using federal and state RICO statutes. If there’s illegal trading, then the problem will continue until those responsible are held to account.
Fair enough - ORBA' - we all want the same here - for this Company and its' stock to recover !
-----------------------------
A number of posters here - just need to remind themselves (now and then):
Only reason Sarissa and Denner is here is' - Du Disaster ruling - which in 'seconds' made AMRN - what Denner and his crew considers 'an undervalued Bio Stock (what they specializes in).
Had things gone as JT expected (when on CNBC (with + $23 on the wall) - no one here would have ever heard of Sarissa.
So you support - FSS - 'Amarin is sinking' - in his 'earth is ending thinking' - or how to read these negative 'copy pastes' ?
-----------------------------------------------
1. For a small Bio Company to have over 300 mil dollar in cash - that means 'you are not dead'. l
2. Amarin VAZKEPA holds 15 years still of patents in Europe - which is an eternity in this Bio game.
3. And maybe most important: Amarin Brand VASCEPA - is likely the most important Drug ever developed - in helping people avoiding a long line of the worst devastating deceases know to man.
---------------------------------------
The challenge is getting one of the big powerful Big Pharmas to understand the potential here. When that happens -VASCEPA / VAZKEPA can / will be a gigantic succes WW in making people of adge have a better' more healthy' - and longer' life 🙂
Ok - 'boring weekend' - so lets play a little🙂
Nah... I hate to break it to you, but when a microcap stock named AMRN makes your house POOF! disappear,... now THAT is wizardry in a land where PRICE IS KING!!
FSS, Is as phony as it gets on these anonymous boards.
------------------------------------------
The guy is 'all over the place' in his wild fantasy projections.
How any one can take this guy serious - 'in the world of facts' and reality' is a continued mystery !
----------------------------
It just again' again' shows - that humans have always been drawn to 'wizards and mysterious truth tellers' - even 100% lack of connection to reality 🙃
exwannabe, What started this debate were Whala saying 'US market is lost' !
The Other day - in another debate on 'what is actually the difference for insurers - in prise - generics - Brand - Whala informed - generics $ 310 - Brand 390.
That difference does not seem that big a mountain to climb - for Amarin - going AG.
Keyword going forward is Volume. Number of prescriptions has to rise - and every means available (including possibly adverting again) must be used to regain/expand US market.
Whala,
Personally I think the US is lost
Serve333, A new 'promising' EPA based product in Phase 3 of trial (where most BO's are made) - wouldn't hurt Amarins (Denner's) chance of making a good deal with one of the major BP's - in say next couple of years.
That there are no new' trials - is no proof that Amarin - are not working on developing new products - it could be 'that they are just not ready for testing yet'.
This has to be D Miller:
https://finance.yahoo.com/quote/AMRN240621P00000500/
Sorry DM - couldn't help it 🙂
---------------------------
Hopefully we are approaching Buyback time. 50 mill dollar will get you 75.400.000 shares - at current SP !
We have reached a point where value of Amarin = 4000 Bitcoins - how sick is that 🙂
---------------------------------
On th AG debate - I still haven't seen any numbers on anything. Like eg. - what will be the cost for Amarin pr bottle 'average' compared to today - selling Brand Vascepa.
Whala said the other day - that the difference for Insures 'today' - is round $80 (B 390 - g 310). That difference doesn't seem like an impossible amount to handle.
----------------------------------
Been in private business 45 years of my life. Always when in trouble making a profit on your product' there in principle is two ways to do something about it:
1. You can raise the price (which is hardly ever possible - if you are in competition)
2. Or' you can reduce your costs - which is to a big extend - what Amarin has done under new MGT and BOD.
3. And when profitable - you can of course raise your your production - as means to improve revenue - given there is a demand.
-------------------------------------
Many ways to reduce cost of production like - atomisation (robots) now a days AI - generally lowering your cost of running your business (again what Amarin has done after the Proxy). Reducing your costs - is a 'never ending process' in the modern world of sale and production.
Whala, Thanks. I feel that this subject might be worth - really 'digging into - further' !
--------------------------------
Who pays 'What' to Whom'. A deeply corrupt system' - if there is no way to get around 'the middle-men' in the US health system - right ?
---------------------------------
Worst thing that could hit American health system were a population that - started to exercise' - avoid sugar' - sort of 'got healthy' - not needing 6-8 drugs to 'get by' - but instead maybe only needed eg. Vascepa - to feel healthy and reach a high age 'feeling great and happy' 🙂
Whala, I'm surprised here'. Thought the difference between Brand and generics would be much bigger ?
--------------------------------------
I know pricing (who pays what to whom) - is an absolutte jungle in the US - with all the 'middle-men' involved. But it sure would be interesting to actually know what 'the true price' the generic producers get for their Vascepa copies ?
Anyway to find such informations - you know off ?
Chromosome, 62k - and possibly expanding if current SP at current level come monday.
And agrees overall in your reasoning !
----------------------------------------
But all the weasels, who hate Denner, have come out of their caves again - right 🙂
CBB, Noticed - and thanks. Your are of course right' - there will NOT BE an answer to something like this idea - and that is OK.
The idea might be understood' and investigated at best - 'still something of an option' - where we are ?
---------------------------------
But your right - even if it were to somehow 'be executed' - we would not hear about it - before it actually happened physically' - in the market.
Deleted post - as suddenly experienced new MAX (earlier HBO) -.'FU with Commercials' - I'm going to skip that stupid streaming service tomorrow !
Denisk, I have just right now forwarded mail to the address you mentioned.
So now we just have to see if 'any one reads it' - and even better answers' 🙂
DCM8, Capt, I have send the mail below to Sarissa mail adresse:
Sarissa personal
Posters from iHub AMRN have suggested i send link - with idea and debate below to you.
If you find the idea worth exploring deeper - there are a number of qualified posters on iHub that will be able to give advice on eg which Statin would be best etc.
In theory if the Combo package already developed - it might be possible the user have a number of the most well-known statins to choose between.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174552297
------------------------------------------
Best Regards
JHN
Capt. Thanks - I know you are the master in contacts on company businesses.
--------------------------------------------------
I might ask you to take over contact - if they should be interested in further debate on the idea (which statin would be best etc.)
Jasbg
DCM8, Thanks again - I'll do that - send the link to debate to them 🙂
DCM8 , Thanks - and yes exactly' - it would open for 'a sort of middleground in pricing' - (not take the big fall to AG all at once).
----------------------------------
I dont have a mail for Sarissa - I might be able to find IR mail address - will try to look for it.
If anyone have a direct mail for Sarissa - I will try to send it to them (link to post) as you suggest !
Some poster here at iHub AMRN - some time back suggested - for a start to maybe make a deal with one of the most common statin producers - to simply put the two product separately in a common package - which in itself would separate it from the generics (and shouldn't be a problem in terms of the FDA - as both products already approved and on the market).
A nice looking package with main results of the R-I printed on the front.
Try to beat that' - you many generic thieves ! 😉
It is logic that one giant generic company after the other - entering the market in the US - would eventually take over main part of the market.
---------------------------------
Why the fraudulent Nevada ruling marts 2020 - is indeed somewhat of a tragic disaster - is not only that it ruined Amarins loyal investors - but maybe even more - that it put to a halt prescriptions on the drug that would have saved most American life's - had Amarin not been forced to give up advertising Vascepa.
If it weren't for the Du disaster likely prescriptions in US would today easily have passed 500.000 - and would have saved thousand of life's in the run.
----------------------------------
Looking from the outside - the optimal option for Amarin in the US market is - two things.
1. When it reach the balancepoint (which might not be so far away) - go AG on the market - and beat the crap out of Generics on their own terms in the US
2. Put every effort into a new product on the market - like eg. Combo - to have on the market ASAP in the US and ROW.
And of course - full steam ahead in Europe and China - Australia - New Zeeland - Canada - Middle East - ROW - with Vazkepa.
We are already ½ way there - now we just have to start doing the harvesting and make real revenue - to pay for the new pipeline products.
----------------------------------
And YES - should there happen to be a BO to BP along the way - we will have to live with that ✌️